These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 26421800)

  • 1. Defining the role of radiofrequency ablation and stereotactic ablative radiotherapy in patients with high-risk, early-stage non-small cell lung cancer.
    Louie AV; Siva S; Senan S
    Cancer; 2016 Jan; 122(2):322-3. PubMed ID: 26421800
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply to defining the role of radiofrequency ablation and stereotactic ablative radiotherapy in patients with high-risk, early-stage non-small cell lung cancer.
    Fernando HC; Dupuy DE
    Cancer; 2016 Jan; 122(2):323-4. PubMed ID: 26421899
    [No Abstract]   [Full Text] [Related]  

  • 3. Radiofrequency ablation in high-risk stage I non-small cell lung cancer.
    Donington JS
    Cancer; 2015 Oct; 121(19):3393-4. PubMed ID: 26096602
    [No Abstract]   [Full Text] [Related]  

  • 4. Stereotactic Body Radiotherapy and Ablative Therapies for Lung Cancer.
    Abbas G; Danish A; Krasna MJ
    Surg Oncol Clin N Am; 2016 Jul; 25(3):553-66. PubMed ID: 27261915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiofrequency ablation of stage IA non-small cell lung cancer in medically inoperable patients: Results from the American College of Surgeons Oncology Group Z4033 (Alliance) trial.
    Dupuy DE; Fernando HC; Hillman S; Ng T; Tan AD; Sharma A; Rilling WS; Hong K; Putnam JB
    Cancer; 2015 Oct; 121(19):3491-8. PubMed ID: 26096694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment advances for medically inoperable non-small-cell lung cancer: emphasis on prospective trials.
    Powell JW; Dexter E; Scalzetti EM; Bogart JA
    Lancet Oncol; 2009 Sep; 10(9):885-94. PubMed ID: 19717090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Stereotactic radiotherapy and radiofrequency ablation for early-stage lung cancer].
    Piegay F; Girard N; Mornex JF
    Bull Cancer; 2012 Nov; 99(11):1077-81. PubMed ID: 23113992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A systematic review of outcomes following stereotactic ablative radiotherapy in the treatment of early-stage primary lung cancer.
    Murray P; Franks K; Hanna GG
    Br J Radiol; 2017 Mar; 90(1071):20160732. PubMed ID: 27885858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereotactic ablative radiotherapy for early stage non-small cell lung cancer: A critical literature review of predictive factors of relapse.
    Loganadane G; Martinetti F; Mercier O; Krhili S; Riet FG; Mbagui R; To H; Le Péchoux C; Levy A
    Cancer Treat Rev; 2016 Nov; 50():240-246. PubMed ID: 27768919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response evaluation after stereotactic ablative radiotherapy for localised non-small-cell lung cancer: an equipoise of available resource and accuracy.
    Gouveia AG; Zalay OC; Chua KL; Moraes FY
    Br J Radiol; 2020 Feb; 93(1106):20190647. PubMed ID: 31778312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Forecasting the impact of stereotactic ablative radiotherapy for early-stage lung cancer on the thoracic surgery workforce.
    Edwards JP; Datta I; Hunt JD; Stefan K; Ball CG; Dixon E; Grondin SC
    Eur J Cardiothorac Surg; 2016 Jun; 49(6):1599-606. PubMed ID: 26796110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiofrequency ablation for non-small-cell lung cancer in a single-lung patient: case report and review of the literature.
    Modesto A; Giron J; Massabeau C; Sans N; Berjaud J; Mazieres J
    Lung Cancer; 2013 Jun; 80(3):341-3. PubMed ID: 23474129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereotactic body radiotherapy (SBRT) for Stage I lung cancer.
    Nagata Y; Kimura T
    Jpn J Clin Oncol; 2018 May; 48(5):405-409. PubMed ID: 29635536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Video assisted thoracoscopic surgery and lobectomy, sublobar resection, radiofrequency ablation, and stereotactic radiosurgery: advances and controversies in the management of early stage non-small cell lung cancer.
    Pennathur A; Abbas G; Christie N; Landreneau R; Luketich JD
    Curr Opin Pulm Med; 2007 Jul; 13(4):267-70. PubMed ID: 17534171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment options for stage I non-small-cell lung carcinoma patients not suitable for lobectomy.
    Forquer JA; Fakiris AJ; McGarry RC; Cheung MK; Watson C; Harkenrider M; Henderson MA; Lo SS
    Expert Rev Anticancer Ther; 2009 Oct; 9(10):1443-53. PubMed ID: 19828006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of stage I lung cancer in high-risk and inoperable patients: comparison of prospective clinical trials using stereotactic body radiotherapy (RTOG 0236), sublobar resection (ACOSOG Z4032), and radiofrequency ablation (ACOSOG Z4033).
    Crabtree T; Puri V; Timmerman R; Fernando H; Bradley J; Decker PA; Paulus R; Putnum JB; Dupuy DE; Meyers B
    J Thorac Cardiovasc Surg; 2013 Mar; 145(3):692-9. PubMed ID: 23174176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [STEREOTACTIC ABLATIVE BODY RADIATION -SABR: A NEW THERAPEUTIC OPTION FOR TREATMENT OF STAGE I LUNG CANCER].
    Appel S; Symon Z
    Harefuah; 2016 Nov; 155(11):672-676. PubMed ID: 28530067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Current Status of Stereotactic Ablative Radiotherapy (SABR) for Early-stage 
Non-small Cell Lung Cancer].
    Shi A; Zhu G
    Zhongguo Fei Ai Za Zhi; 2016 Jun; 19(6):389-93. PubMed ID: 27335303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical salvage following stereotactic body radiotherapy for early-stage NSCLC.
    Allibhai Z; Cho BC; Taremi M; Atallah S; Hope A; Hwang D; Keshavjee S; Tsao M; Yasufuku K; Kim SW; Bezjak A
    Eur Respir J; 2012 Apr; 39(4):1039-42. PubMed ID: 22467727
    [No Abstract]   [Full Text] [Related]  

  • 20. Primary Treatment Options for High-Risk/Medically Inoperable Early Stage NSCLC Patients.
    Jones GC; Kehrer JD; Kahn J; Koneru BN; Narayan R; Thomas TO; Camphausen K; Mehta MP; Kaushal A
    Clin Lung Cancer; 2015 Nov; 16(6):413-30. PubMed ID: 26027433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.